Cell Cycle Dependency of Gallium Uptake and Cytotoxicity in Human Cell Lines of Hematological Malignancies

References

• Sinclair W.K. The combined effect of hydroxyurea and X-rays on Chinese hamster cells in vitro. Cancer Research 1968; 28: 198–206
   PubMed Web of Science ®Google Scholar
• Minderman H., Linssen P., Wessels J., Haanen C. Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin. Anticancer Research 1993; 13: 1161–1165
   PubMed Web of Science ®Google Scholar
• Korbelik M., Skov K.A. Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research 1989; 119: 145–156
   PubMed Web of Science ®Google Scholar
• Sun J.R., Brown J.M. Lack of differential radio-sensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiation Research 1993; 133: 252–256
   PubMed Web of Science ®Google Scholar
• Minehan K.J., Bonner J.A. The interaction of etoposide with radiation: variation in cytotoxicity with the sequence of treatment. Life Sciences 1993; 53: PL237–242
   PubMed Web of Science ®Google Scholar
• Giocanti N., Hennequin C., Balosso J., Mahler M., Favaudon V. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Research 1993; 53: 2105–2111
   PubMed Web of Science ®Google Scholar
• Miller E.M., Kinsella T.J. Radiosensitization by fluorodeoxyuridine: effects of thymidilate synthase inhibition and cell synchronization. Cancer Research 1992; 52: 1687–1694
   PubMed Web of Science ®Google Scholar
• Keating M.J., McLaughlin P., Plunkett W., Robertson L.E, O'Brien S., Gandhi V. Fludarabine-present status and future developments in chronic lymphocytic leukemia and lymphoma. Annals of Oncology 1994; 5 Suppl.2: 79–83
   PubMedGoogle Scholar
• Choy H., Rodriguez F.F., Koester S., Hilsenbeck S., Von Hoff D.D. Investigation of taxol as a potential radiation sensitizer. Cancer 1993; 71: 3774–3778
   PubMed Web of Science ®Google Scholar
• Hahn S.M., Liebmann J.E., Cook J., Fisher J., Goldspiel B., Venzon D. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer 1993; 72: 2705–2711
   PubMed Web of Science ®Google Scholar
• Nelson B., Hayes R.L., Edwards C.L., Kniseley R.M., Andrews G.A. Distribution of gallium in human tissues after intravenous administration. Journal of Nuclear Medicine 1972; 13: 92–100
   PubMed Web of Science ®Google Scholar
• Watson E.E., Cloutier R.J., Gibbs W.D. Whole-body retention of 67Ga-citrate. Journal of Nuclear Medicine 1973; 14: 840–842
   PubMed Web of Science ®Google Scholar
• Jonkhoff A.R., Huijgens P.C., Versteegh R.T., Van Dieren E.B., Ossenkoppele G.J., Martens H.J.M. Gallium-67 radiotoxicity in human U-937 lymphoma cells. British Journal of Cancer 1993; 67: 693–700
   PubMed Web of Science ®Google Scholar
• Van Leeuwen-Stok A.E., Dräger A.M., Schuurhuis G.J., Platier A.W.J., Teule G.J.J., Huijgens P.C. Gallium-67 in the human lymphoid cell line U-715: uptake, cytotoxicity and intracellular localization. International Journal of Radiation Biology 1992; 64: 749–759
   Web of Science ®Google Scholar
• Jonkhoff A.R., Huijgens P.C., Versteegh R.T., Van Lingen A., Ossenkoppele G.J., Drager A.M. Radiotoxicity of 67-gallium on myeloid leukemic blasts. Leukemia Research 1995; 19: 169–174
   PubMed Web of Science ®Google Scholar
• Huijgens P.C., Jonkhoff A.R., Hoekstra O.S., Ossenkoppele G.J., Teule G.J.J. Therapeutic potential of intravenous 67-Gallium in non-Hodgkin's lymphoma. European Journal of Hematology 1993; 51: 206–208
   PubMed Web of Science ®Google Scholar
• Harris A.W., Sephton R.G. Transferrin promotion of 67Ga and 59Fe uptake by cultured mouse myeloma cells. Cancer Research 1977; 37: 3646–3648
   Google Scholar
• Pelosi-Testa E., Testa U., Samoggia P., Salvo G., Camagna A. Expression of transferrin receptor in human erythroleukemic lines: Regulation in the plateau and exponential phase of growth. Cancer Research 1986; 46: 5330–5334
   PubMed Web of Science ®Google Scholar
• Chitambar C.R., Massey E.J., Seligman P.A. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Journal of Clinical Investigations 1983; 73: 1314–1325
   Web of Science ®Google Scholar
• Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). International Journal of Cancer 1976; 17: 565–577
   PubMed Web of Science ®Google Scholar
• Nilsson K., Sundström C. Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. International Journal of Cancer 1974; 13: 802–823
   Web of Science ®Google Scholar
• Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukemia cells in suspension cultures. Nature 1977; 270: 347–349
   PubMed Web of Science ®Google Scholar
• Keng P.C., Li C.K.N., Wheeler K.T. Synchronization of 9L Rat Brain tumor cells by centrifugal elutriation. Cellular Biophysics 1980; 2: 191–206
   PubMedGoogle Scholar
• Vindelølash;v L.L., Christensen I.J. Detergent and proteolytic enzyme based techniques for nuclear isolation and DNA content analysis. Methods in Cell Biology 1994; 41: 219–292
   PubMed Web of Science ®Google Scholar
• Price P., McMillan T.J. Use of the tetrazolium assay in measuring response of human tumor cells to ionizing radiation. Cancer Research 1990; 50: 1392–1396
   PubMed Web of Science ®Google Scholar
• Steel G.G. Terminology in the description of drug-radiation interactions. International Journal of Radiation Oncolology, Biology and Physics 1979; 5: 1145–1150
   PubMed Web of Science ®Google Scholar
• Bhalla K., Swerdlow P., Grant S. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabino-furanosylcytosine in highly resistant human leukemia cells. Blood 1991; 78: 2937–2944
   PubMed Web of Science ®Google Scholar
• Boulikas T. Poly (ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis. Anticancer Reserach 1992; 12: 885–898
   PubMed Web of Science ®Google Scholar
• Poot M., Schuster A., Hoehn H. Cytostatic synergism between bromodeoxyuridine, bleomycin, cisplatin and chlorambucil demonstrated by a sensitive cell kinetic assay. Biochemical Pharmacology 1991; 41: 1903–1909
   PubMed Web of Science ®Google Scholar
• Just G., Holler E. Enhanced levels of cyclic AMP, adenosine(5′)tetriphospho(5′)adenosine and nucleoside 5′-triphosphates in mouse leukemia P388/D1 after treatment with cis-diamine-di-chloroplatinum(II). Biochemical Pharmacology 1991; 42: 285–294
   PubMed Web of Science ®Google Scholar
• Goto H., Shimazaki C., Hirata T., Ashihara E., Ohkawa K., Oku N. Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemia. Acta Hematologica 1993; 89: 144–148
   PubMed Web of Science ®Google Scholar
• Smith P.J., Rackstraw C., Cotter F. DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells. Annals Hematology 1994; 69(Suppl. 1)S7–11
   PubMed Web of Science ®Google Scholar
• Wang J.Z., Tian X., Tsumura H., Shimura K., Ito H. Antitumor activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11) and its mechanisms. Anti-Cancer Drug Design 1993; 8: 193–202
   PubMedGoogle Scholar
• Sinha B.K., Yamazaki H., Eliot H.M., Schneider E., Borner M.M., O'Connor P.M. Relationships between protooncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochimica Biophysica Acta 1995; 1270: 12–18
   PubMed Web of Science ®Google Scholar
• Skog S., Heiden T., Eriksson S., Wallstrom B., Tribukait B. Hydroxyurea-induced cell death in human T lymphoma cells as related to imbalance in DNA/protein cycle and deoxyribonucleotide pools and DNA strand breaks. Anti-Cancer Drugs 1992; 3: 379–386
   PubMed Web of Science ®Google Scholar
• Hedley D., Rugg C., Musgrove E., Taylor I. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis. Journal Cellular Physiology 1985; 124: 61–66
   PubMed Web of Science ®Google Scholar
• Van Dierendonck J.H., Wijsman J.H., Keijzer R., Vande Velde C.J., Cornelisse C.J. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. American Journal of Pathology 1991; 138: 1165–1172
   PubMed Web of Science ®Google Scholar
• Persohn L.K., Drewinko B., Loo T.L. Uptake of 1-beta-D-arabinofuranosyl-cytosine and prednisolone by synchronized human lymphoma cells. Medicin in Pediatric Oncology 1976; 2: 291–297
   PubMedGoogle Scholar
• Lange Wantzin G. Cell proliferation and DNA dependent DNA polymerase estimation in acute lymphoblastic leukemia during treatment with prednisone and vincristine. Scandinavian Journal of Hematology 1979; 22: 375–385
   PubMedGoogle Scholar
• Chen Y.H., Feng X.X., Schilder I. Effect of vincristine, adriamycin and glucocorticoids on myeloma cells in vitro. Acta Hematologica 1993; 89: 61–69
   PubMed Web of Science ®Google Scholar
• Erlichman C., Wu A. Resistance of MGH-U1 bladder cancer spheroids to vincristine. Anticancer Research 1992; 12: 1233–1236
   PubMed Web of Science ®Google Scholar
• Jonkhoff A.R., Van Dieren E.B., Huijgens P.C., Versteegh R.T., Dräger A.M., Loosdrecht A.A. Biological effectiveness of 67-Galium decay in HL-60 cells compared with external low dose rate gamma irradiation: effects on proliferation, G2 arrest and clonogenic capacity. International Journal of Radiation Oncology Biology and Physics 1994; 30: 117–124
   PubMed Web of Science ®Google Scholar
• Neckers L.M. Regulation of transferrin receptor expression and control of cell growth. Pathobiology 1991; 59: 11–18
   PubMed Web of Science ®Google Scholar
• Chitambar C.R., Matthaeus W.G., Antholine W.E., Graff K., O'brien W.J. Inhibition of leukemic HL-60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with Hydroxyurea. Blood 1988; 72: 1930–1936
   PubMed Web of Science ®Google Scholar
• Sinclair W.K. Cyclic X-ray responses in mammalian cells in vitro. Radiation Research 1968; 33: 620–643
   PubMed Web of Science ®Google Scholar
• Steel G.G. Cell synchronization unfortunately may not benefit cancer therapy. Radiotherapeutic Oncology 1994; 32: 95–97
   PubMed Web of Science ®Google Scholar
• Fram R.J., Kufe D.W. Inhibition of DNA excision repair and the repair of X-ray induced DNA damage by cytosine-arabinoside and hydroxyurea. Pharmacological Therapy 1985; 31: 165–176
   PubMed Web of Science ®Google Scholar
• Chitambar C.R., Narasimhan J., Guy J., Sem D.S., O'brien W.J. Inhibition of the ribonucleotide reductase by gallium in murine L1210 cells. Cancer Research 1991; 51: 6199–6201
   PubMed Web of Science ®Google Scholar
• Berry R.J., Huckle J.M. Radiation and methotrexate effects on stationary phase cells. British Journal of Radiology 1972; 45: 110–711
   PubMedGoogle Scholar
• Sharma S.C., Schimke R.T. Enhancement of the frequency of Methotrexate resistance by gamma-radiation in Chinese hamster ovary and mouse 3T3 cells. Cancer Research 1989; 49: 3861–3866
   PubMed Web of Science ®Google Scholar